[Ip-health] Watch HepC activist video from TAG/OSF/MSF meeting

Joanna Keenan-Siciliano joanna.l.keenan at gmail.com
Mon Jul 29 07:50:46 PDT 2013

Every year, the Hepatitis C virus (HCV) and associated complications claim
350,000 lives.  As many as 185 million people worldwide are now thought to
be infected.  The virus combines with HIV to deadly effect.

Yet this is a problem that largely goes unaddressed.  Most of the burden of
disease occurs in developing countries.  And multiple barriers – including
the price of diagnostics, the lack of laboratory capacity, and the cost and
toxicity of treatment - are used to justify why the epidemic goes ignored.

Yet HCV is curable and promisingly, the standard of care is rapidly
changing. The unprecedented progresses in HCV drug development means
effective, safe and tolerable oral regimens will soon be available. Lab
technologies are increasingly simplified, opening new prospects for
decentralised care, and for reaching more people with diagnosis and
treatment, even in resource-poor settings.

The time to seize this historic opportunity is upon us. In September 2012,
Médecins Sans Frontières, the Open Society Foundations and Treatment Action
Group,  joined forces with activists, researchers, UN and government
representatives to identify priority issues, share information and develop
strategies to overcome the barriers that prevent access to HCV treatment in
developing countries, both today and in the future.

This short video highlights their concerns, and their hopes:

Joanna Keenan
Press Officer
Médecins Sans Frontières - Access Campaign
P: +41 22 849 87 45
M: +41 79 203 13 02
E: joanna.keenan[at]geneva.msf.org
T: twitter.com/joanna_keenan


More information about the Ip-health mailing list